These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1575127)

  • 1. Reperfusion of the infarct-related coronary artery limits left ventricular expansion beyond myocardial salvage.
    Marino P; Destro G; Barbieri E; Bicego D
    Am Heart J; 1992 May; 123(5):1157-65. PubMed ID: 1575127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial.
    Marino P; Zanolla L; Zardini P
    J Am Coll Cardiol; 1989 Nov; 14(5):1149-58. PubMed ID: 2681320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction.
    Clemmensen P; Ohman EM; Sevilla DC; Wagner NB; Quigley PS; Grande P; Wagner GS
    Am J Cardiol; 1992 Dec; 70(18):1391-6. PubMed ID: 1442606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
    Wackers FJ; Terrin ML; Kayden DS; Knatterud G; Forman S; Braunwald E; Zaret BL
    J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size.
    Hirayama A; Adachi T; Asada S; Mishima M; Nanto S; Kusuoka H; Yamamoto K; Matsumura Y; Hori M; Inoue M
    Circulation; 1993 Dec; 88(6):2565-74. PubMed ID: 8080490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction.
    Chareonthaitawee P; Christian TF; Hirose K; Gibbons RJ; Rumberger JA
    J Am Coll Cardiol; 1995 Mar; 25(3):567-73. PubMed ID: 7860898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function.
    Saran RK; Been M; Furniss SS; Hawkins T; Reid DS
    Br Heart J; 1990 Aug; 64(2):113-7. PubMed ID: 2393608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic therapy reduces the incidence of left ventricular thrombus after anterior myocardial infarction. Relationship to vessel patency and infarct size.
    Pizzetti G; Belotti G; Margonato A; Carlino M; Gerosa S; Carandente O; Chierchia SL
    Eur Heart J; 1996 Mar; 17(3):421-8. PubMed ID: 8737217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of late administration of tissue-type plasminogen activator on left ventricular remodeling and function after myocardial infarction.
    Bonaduce D; Petretta M; Villari B; Breglio R; Conforti G; Montemurro MV; Lanzillo T; Morgano G
    J Am Coll Cardiol; 1990 Dec; 16(7):1561-8. PubMed ID: 2123907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators.
    Habib GB; Heibig J; Forman SA; Brown BG; Roberts R; Terrin ML; Bolli R
    Circulation; 1991 Mar; 83(3):739-46. PubMed ID: 1900223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction.
    Leung WH; Lau CP
    J Am Coll Cardiol; 1992 Aug; 20(2):307-13. PubMed ID: 1634665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of timing of thrombolytic therapy as shown in clinical trials.
    Pepine CJ
    Clin Cardiol; 1990 Aug; 13(8 Suppl 8):VIII12-7. PubMed ID: 2119925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction.
    Schulman SP; Weiss JL; Becker LC; Guerci AD; Shapiro EP; Chandra NC; Siu C; Flaherty JT; Coombs V; Taube JC
    Am J Cardiol; 1995 Oct; 76(11):764-70. PubMed ID: 7572651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular remodelling in the year after myocardial infarction: an echocardiographic, haemodynamic, and radionuclide angiographic study.
    Bonaduce D; Petretta M; Morgano G; Villari B; Bianchi V; Conforti G; Salemme L; Themistoclakis S; Pulcino A
    Coron Artery Dis; 1994 Feb; 5(2):155-62. PubMed ID: 8180745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.
    Topol EJ; Califf RM; Vandormael M; Grines CL; George BS; Sanz ML; Wall T; O'Brien M; Schwaiger M; Aguirre FV
    Circulation; 1992 Jun; 85(6):2090-9. PubMed ID: 1591828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.